approval
saveSYNJARDY (EMPAGLIFLOZIN) — FDA approval
community read0 votes
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 1 completionPolfa Tarchomin SA — empagliflozin (Phase I Trial Completion)Apr 28, 2026 · 156d ago
- approvalJARDIANCE (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025 · 342d ago
- approvalSYNJARDY (EMPAGLIFLOZIN) — FDA approvalOct 24, 2025 · 342d ago
- approvalSYNJARDY (EMPAGLIFLOZIN) — FDA approvalMar 7, 2025 · 573d ago
- approvalSYNJARDY (EMPAGLIFLOZIN) — FDA approvalOct 30, 2023 · 1067d ago
- approvalJARDIANCE (EMPAGLIFLOZIN) — FDA approvalSep 21, 2023 · 1106d ago
- approvalJARDIANCE (EMPAGLIFLOZIN) — FDA approvalSep 12, 2023 · 1115d ago
- approvalJARDIANCE (EMPAGLIFLOZIN) — FDA approvalJun 20, 2023 · 1199d ago
same company · ±60 days · 6
- approvalSYNJARDY: SYNJARDY (EMPAGLIFLOZIN) — FDA approvalJun 20, 2023
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalJun 20, 2023
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalJun 20, 2023
- approvalSYNJARDY: JARDIANCE (EMPAGLIFLOZIN) — FDA approvalJun 20, 2023
- approvalCYLTEZO: CYLTEZO (ADALIMUMAB-ADBM) — FDA approvalJun 30, 2023
- approvalCYLTEZO: CYLTEZO (ADALIMUMAB-ADBM) — FDA approvalJul 19, 2023
🐶 often sniffed alongside
top 6- tagApproval70 co-mentions · 35 sources
- drugTRIJARDY XR35 co-mentions · 35 sources
- companyBoehringer Ingelheim Corp35 co-mentions · 35 sources
- tagSmall Molecule35 co-mentions · 35 sources
- drugSYNJARDY XR15 co-mentions · 15 sources
- drug(empagliflozin + metformin hydrochloride ER)15 co-mentions · 15 sources
comments(0)
5-min edit window · permanent after that